Antidepressants may have to fight for Part D coverage

Share this article:

The Centers for Medicare and Medicaid Services (CMS) is proposing a new Part D access rule for immunosuppressants and antidepressants that would no longer require every drug in every class to have a place on the formulary, BioCentury reports. These two drug classes have been part of what's considered a protected class in Medicare Part D, a category which includes anticonvulsants, antineoplastics, antipsychotics and antiretrovirals.

The proposed rule says the remaining four classes would still be protected. The proposed change could give payers more leverage in rebate negotiations with pharmaceutical firms—insurers have claimed, the rule notes, that the protected status means companies have no incentive to lower prices because the current rule secures Part D formulary status.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.